In vivo human time-exposure study of orally dosed commercial silver nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 1, 2014, Pages 1-9

  Munger, Mark A ^a,b   Radwanski, Przemyslaw ^a   Hadlock, Greg C ^a   Stoddard, Greg ^b   Shaaban, Akram ^b   Falconer, Jonathan ^a   Grainger, David W ^a   Deering Rice, Cassandra E ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Biological activity nanoparticles; Nanotechnology; Nanotoxicology oral ingestion; Safety research

Indexed keywords

HEALTH ASSESSMENTS; HEALTHY VOLUNTEERS; MORPHOLOGICAL CHANGES; NANO PARTICULATES; ORAL INGESTION; REACTIVE OXYGEN SPECIES; SAFETY RESEARCH; SILVER NANOPARTICLES;

BIOACTIVITY; BODY FLUIDS; MAGNETIC RESONANCE IMAGING; MEDICAL NANOTECHNOLOGY; METABOLISM; NANOPARTICLES; NANOTECHNOLOGY; TOXICITY;

SILVER;

REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE;

ABDOMEN; ARTICLE; BLOOD CELL COUNT; HEART; HUMAN; IN VIVO STUDY; INTENTION TO TREAT ANALYSIS; LUNG; NANOTOXICOLOGY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SYSTEMS; PROSPECTIVE STUDY; SPUTUM; URINALYSIS;

BIOLOGICAL ACTIVITY NANOPARTICLES; NANOTECHNOLOGY; NANOTOXICOLOGY ORAL INGESTION; SAFETY RESEARCH;

ADULT; AGED; BLOOD CELL COUNT; FEMALE; HEART; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; MALE; METAL NANOPARTICLES; MIDDLE AGED; RADIOGRAPHY, THORACIC; REACTIVE OXYGEN SPECIES; SILVER; SPUTUM; URINALYSIS;

EID: 84890978504     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.06.010     Document Type: Article

References (50)

1. The Project on Emerging Nanotechnologies. Nanotech-enabled Consumer Products Continue to Rise Accessed: 01/12/2012. http://www.nanotechproject.org/news/archive/9231/.
2. Grainger D.W. Nanotoxicity assessment: all small talkα. Adv Drug Deliv Rev 2009, 61(6):419-421.
3. Oberdörster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 2010, 267(1):89-105.
4. Becker H., Herzberg F., Schulte A., Kolassa-Gehring M. The carcinogenic potential of nanoparticles, their release from products and options for regulating them. Int J Hyg Environ Health 2011, 214(3):231-238.
5. Johnston H.J., Hutchison G., Christensen F.M., Peters S., Hankin S., Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 2010, 40(4):328-346.
6. Samberg M.E., Orndorff P.E., Monteiro-Riviere N. Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods. Nanotoxicol 2011, 5(2):244-253.
7. 20. Mat Resear Innovat 2007, 11:3-18.
8. Atiyeh B.S., Costagliola M., Hayek S.N., Dibbo S.A. Effect of silver on burn wound infection control and healing; review of the literature. Burns 2007, 33:139-148.
9. Elechiguerra J.L., Burt J., Morones J.R., Camacho-Bragado A., Gao X., Lara H.H., Yacaman M.J. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol 2005, 3:6.
10. Bhol K.C., Alroy J., Schechter P.J. Anti-inflammatory effects of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin Exp Dermatol 2004, 29:282-287.
11. Takenaka S., Karg E., Roth C., Schultz H., Ziesenis A., Heinzmann U., et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 2001, 109(Suppl. 4):547-551.
12. Carlson C., Hussain S.M., Schrand A.M., Braydich-Stolle L.K., Hess K.L., Jones R.L., et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 2008, 112(43):13608-13619.
13. Soto K., Garza K.M., Murr L.E. Cytotoxic effects of aggregated nanomaterials. Acta Biomater 2007, 3:351-358.
14. Sung J.H., Ji J.H., Yoonn J.U., Kim D.S., Song M.Y., Jeong J., et al. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol 2008, 20(6):567-574.
15. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlarger J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol Vitro 2005, 975-983.
16. Arora S., Jain J., Rajwade J.M., Paknikar K.M. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol Appl Pharmacol 2009, 236:310-318.
17. Park E.J., Yi J., Kim Y., Choi K., Park K. Silver nanoparticles induce cytoxicity by a Trojan-horse type mechanism. Toxicol Vitro 2010, 24:872-878.
18. Kawata K., Osawa M., Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses in HepG2 human hepatoma cells. Environ Sci Technol 2009, 43:6046-6051.
19. Hussain S.M., Javorina A.K., Schrand A.M., Duhart H.M., Ali S.F., Schlager J.J. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci 2006, 92(2):456-463.
20. Rosas-Hernandeza H., Jimenez-Badilloa S., Martinez-Cuevasa P.P., Gracia-Espino E., Terrones H., Terrones M., et al. Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings. Toxicol Lett 2009, 191(2-3):305-313.
21. Braydich-Stolle L., Hussain S., Schlager J.J., Hofmann M.C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 2005, 88:412-419.
22. Ahamed M., Karns M., Goodson M., Rowe J., Hussain S.M., Schlager J.J., Hong Y. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol 2008, 233(3):404-410.
23. United States Patent USP 7,135,195, Holladay; R.J. Christensen; H. "Treatment of humans with colloidal silver composition" (2006); and United States Patent 6,214,299, Holladay; R.J. Christensen; H. Apparatus and method for producing antimicrobial silver solution (2001).
24. Yang J., Wu K., Konák C., Kopecek J. Dynamic light scattering study of self-assembly of HPMA hybrid graft copolymers. Biomacromolecules 2008, 9:510-517.
25. Tien D.C., Tseng K.H., Liao C.Y., Huang J.C., Tsung T.T. Discovery of ionic silver in silver nanoparticle suspension fabricated by arc discharge method. J Alloys Compd 2008, 463(1):408-411.
26. Gibson P.G., Wlodarczyk J.W., Hensley M.J., Gleeson M., Henley R.L., Cripps A.W., Clancy R.L. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponiveness in childhood. Am J Respir Crit Care Med 1998, 158:36-41.
27. Cordray P., Doyle K., Edes K., Moos P.J., Fitzpatrick F.A. Oxidation of 2-cys-perosiredoxins by arachidonic acid peroxide metabolites of lipoxygenases and cycloxygenase-2*. J Biol Chem 2007, 282(45):32623-32629.
28. Cameron M.D., Aust S.D. Degradation of chemicals by reactive radicals produced by cellobiose dehydrogenase from Phanerochaete chyrsoporium. Arch Biochem Biophys 1999, 367(1):115-121.
29. Deering-Rice C.E., Johansen M.E., Roberts J.K., Thomas K.C., Romero E.G., Lee J., et al. Transient receptor potential vanilloid-1 (TRPV1) is a mediator of lung toxicity for coal fly ask particulate material. Mol Pharmacol 2012, 81(3):411-419.
30. Roy S., Basak S., Ray P., Dasgupta A.K. Double plasmonic profile of tryptophan-silver nano-crystals - temperature sensing and laser induced antimicrobial activity. Photonics Nanostruct Fund Appl 2012, 10(4):506-515.
31. Kreibig U., Vollmer M. Optical properties of metal clusters 1995, 25:532. Springer.
32. Yamamato S., Fujiwara K., Wararai H. Surface-enhanced Raman scattering from oleate-stabilized silver colloids at a liquid/liquid interface. Anal Sci 2004, 20:1347-1352.
33. Link S., El-Sayed M.A. Optical properties and ultrafast dynamics of metallic nanocrystals. Annu Rev Phys Chem 2003, 54:331-366.
34. Angelescu D.G., Vasilescu M., Anastasescu M., Baratoiu R., Donescu D., Teodorescu V.S. Synthesis and association of Ag(0) nanoparticles in aqueous Pluronic F127 triblock copolymer solutions. Colloids Surf A 2011, 394:57-66.
35. Brause R., Moeltgen H., Kleinermanns K. Characterization of laser-ablated and chemically reduced silver colloids in aqueous solution by UV/VIS spectroscopy and STM/SEM microscopy. Appl Phys B: Lasers Optics 2002, 75:711-716.
36. Lee K.S., El-Sayed M.A. Gold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal composition. J Phys Chem B 2006, 110:19220-19225.
37. Jin R., Cao Y., Mirkin C.A., Kelly K.L., Schatz G.C., Zheng J.G. Photoinduced conversion of silver nanospheres to nanoprisms. Science 2001, 294:1901-1903.
38. Schleh C., Semmler-Behnke M., Lipka J., Wenk A., Hirn S., Schäffler M., et al. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 2012, 6(1):36-46.
39. Panyala N.R., Peña-Mendez E.M., Havel J. Silver or silver nanoparticles: a hazardous threat to the environment and human healthα. J Appl Biomed 2008, 6:117-129.
40. Xia T., Li N., Nel A.E. Potential health impact of nanoparticles. Annu Rev Public Health 2009, 30:137-150.
41. Ahamed M., Alsalhi M.S., Siddiqui M.K.J. Silver nanoparticle applications and human health. Clin Chim Acta 2010, 411:1841-1848.
42. Nel A., Xia T., Mädler L., Li N. Toxic Potential of Materials at the Nanolevel. Science 2006, 311:622-627.
43. Fischer H.C., Chan W.C.W. Nanotoxicity: the growing need for an in vivo study. Curr Opin Biotech 2007, 18:565-571.
44. Greulich C., Kittler S., Epple M., Muhr G., Koller M. Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langerbecks Arch Surg 2009, 394:495-502.
45. Lamb J.G., Hathaway L.B., Munger M.A., Raucy J.L., Franklin M.R. Nanosilver particle effects on drug metabolism in vitro. Drug Metab Dispos 2010, 38:2246-2251.
46. Kim Y.S., Song M.Y., Park J.D., Song K.S., Ryu H.R., Chung Y.H., et al. Subchronic oral toxicity of silver nanoparticles. Part Fibre Toxicol 2010, 20.
47. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 2006, 8:1795-1807.
48. Jun E.-A., Lim K.-M., Kim K., Bae O.N., Noh J.Y., Chung K.H., et al. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicol 2011, 5(2):157-167.
49. O'Hagan D.T. The intestinal uptake of particles and implications for drug and antigen delivery. J Anal 1996, 189:477-482.
50. Schleh C., Semmler-Behnke M., Lipka J., Wenk A., Hirn S., Schäffler M., Schmid G., Simno U., Kreyling W.G. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicol 2012, 6(1):36-46.